SG10201907542SA - Active substances of bifidobacterium lactis gkk2, composition comprising the same and method of promoting longevity using the same - Google Patents
Active substances of bifidobacterium lactis gkk2, composition comprising the same and method of promoting longevity using the sameInfo
- Publication number
- SG10201907542SA SG10201907542SA SG10201907542SA SG10201907542SA SG10201907542SA SG 10201907542S A SG10201907542S A SG 10201907542SA SG 10201907542S A SG10201907542S A SG 10201907542SA SG 10201907542S A SG10201907542S A SG 10201907542SA SG 10201907542S A SG10201907542S A SG 10201907542SA
- Authority
- SG
- Singapore
- Prior art keywords
- same
- composition
- active substances
- bifidobacterium lactis
- promoting longevity
- Prior art date
Links
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 229940009289 bifidobacterium lactis Drugs 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW107128656A TWI740057B (en) | 2018-08-16 | 2018-08-16 | An active substance of bifidobacterium lactis gkk2, a composition comprising thereof and its use for promoting longevity |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201907542SA true SG10201907542SA (en) | 2020-03-30 |
Family
ID=69523201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201907542SA SG10201907542SA (en) | 2018-08-16 | 2019-08-16 | Active substances of bifidobacterium lactis gkk2, composition comprising the same and method of promoting longevity using the same |
Country Status (6)
Country | Link |
---|---|
US (1) | US11058733B2 (en) |
JP (1) | JP7060555B2 (en) |
CN (1) | CN110835615B (en) |
MY (1) | MY192161A (en) |
SG (1) | SG10201907542SA (en) |
TW (1) | TWI740057B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI740199B (en) * | 2019-08-30 | 2021-09-21 | 葡萄王生技股份有限公司 | A composition for modulation of testosterone and its use |
TWI825324B (en) * | 2020-06-17 | 2023-12-11 | 國立陽明交通大學 | Anti-aging uses of citrus extract ingredients |
CN115025129B (en) * | 2021-03-05 | 2024-04-19 | 葡萄王生技股份有限公司 | Composition containing lactobacillus and use thereof for preventing and/or improving skin aging |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2816564B2 (en) * | 1989-05-30 | 1998-10-27 | 日研フード株式会社 | Lactic acid bacteria preparation |
WO2014141265A1 (en) | 2013-03-14 | 2014-09-18 | Nofar Gil | Inhibition of neurodegenerative disease by grape seed extract, green tea extract and probiotic bacteria |
CN104560829B (en) * | 2015-01-14 | 2017-11-14 | 贵州大学 | One plant of fragrant pig source property norcholesterol, oxytolerant Bifidobacterium BZ25 |
CN104996992A (en) | 2015-04-10 | 2015-10-28 | 劲膳美生物科技股份有限公司 | Medical formula food for muscle attenuation syndromes |
CN104839699A (en) | 2015-04-23 | 2015-08-19 | 劲膳美生物科技股份有限公司 | Heart disease non-total nutrient formula food |
TWI636133B (en) | 2017-10-20 | 2018-09-21 | 葡萄王生技股份有限公司 | A lactobacillus plantarum, composition, culturing method and use of elimination of body fat, reduction of hepatomegaly and/or anti-inflammatory |
TWI651412B (en) | 2017-11-01 | 2019-02-21 | 葡萄王生技股份有限公司 | Novellactobacillus paracaseigks6 for improving metabolic syndromes, its medium, incubation method, use, pharmaceutical composition and edible composition |
CN108220193B (en) * | 2018-01-08 | 2021-01-15 | 金华银河生物科技有限公司 | Bifidobacterium lactis, bifidobacterium lactis freeze-dried powder and preparation method thereof |
-
2018
- 2018-08-16 TW TW107128656A patent/TWI740057B/en active
- 2018-09-17 CN CN201811083391.2A patent/CN110835615B/en active Active
-
2019
- 2019-08-16 US US16/542,608 patent/US11058733B2/en active Active
- 2019-08-16 SG SG10201907542SA patent/SG10201907542SA/en unknown
- 2019-08-16 JP JP2019149363A patent/JP7060555B2/en active Active
- 2019-08-16 MY MYPI2019004729A patent/MY192161A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP7060555B2 (en) | 2022-04-26 |
JP2020075902A (en) | 2020-05-21 |
CN110835615A (en) | 2020-02-25 |
US11058733B2 (en) | 2021-07-13 |
US20200054692A1 (en) | 2020-02-20 |
TWI740057B (en) | 2021-09-21 |
MY192161A (en) | 2022-08-03 |
CN110835615B (en) | 2023-09-08 |
TW202008996A (en) | 2020-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201907552TA (en) | An active substance of lactobacillus paracasei gks6, a composition comprising thereof and its use for promoting longevity | |
IL263238A (en) | Composition of probiotics and digestive enzymes and method of preparing and using the same | |
EP3722412A4 (en) | Novel bifidobacterium bacteria and composition including novel bifidobacterium bacteria | |
PT3793008T (en) | Positive electrode material, preparation method therefor, and use thereof | |
EP3733715A4 (en) | Triabody, preparation method and use thereof | |
ZA202105317B (en) | Composite material, its preparation method, and its use as electrode material | |
SG10201907542SA (en) | Active substances of bifidobacterium lactis gkk2, composition comprising the same and method of promoting longevity using the same | |
EP3505195A4 (en) | Regenerative medical material, preparation method therefor, and use thereof | |
PT3580208T (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
EP3680331A4 (en) | Modified cas9 protein, and use thereof | |
SG10201910740UA (en) | Lactobacillus fermentum gkf3, composition comprising the strain and method for improving psychataxia using the same | |
IL281171A (en) | Cellulose-synthase-like enzymes and uses thereof | |
EP3636744A4 (en) | Lactobacillus curvatus wikim55 having activity of promoting hair growth, and composition containing same. | |
ZA202103259B (en) | Modified cas9 protein, and use thereof | |
EP3521415A4 (en) | Novel lactobacillus sakei and composition comprising same | |
EP3812452A4 (en) | Bifidobacterium lactis bl-99 and application thereof | |
EP4245840A4 (en) | Probiotic system and use thereof | |
IL278036A (en) | Hpk1 inhibitors, preparation method and application thereof | |
HUE053801T2 (en) | Cathode active material and preparation method thereof | |
SG10201907547RA (en) | An active substance of lactobacillus plantarum gkm3, a composition comprising thereof and its use for promoting longevity | |
SG11202103103TA (en) | Gdsl lipase, genetically-engineered bacteria and application thereof | |
EP3639845A4 (en) | Il-15 protein complex pharmaceutical composition and uses thereof | |
EP4039803A4 (en) | Engineered human immune cells, preparation method and application thereof | |
GB2568843B (en) | Lactobacillus plantarum proliferator, and fermented product added with the proliferator and preparation method thereof | |
WO2017123610A3 (en) | Bacteria engineered to detoxify deleterious molecules |